Related Experiment Videos
Novel predictors of acute coronary syndrome outcomes
1Systems and Technology Department, University of Texas at Houston School of Nursing, 1100 Holcombe, Suite 5.528, Houston, TX 77030, USA. lorraine.frazier@uth.tmc.edu
Insights
Identifying prognostic inflammatory markers for acute coronary syndrome (ACS) is crucial. Endothelial inflammatory markers (EIMs) show potential for predicting patient outcomes in ACS, possibly outperforming general markers like C-reactive protein.
Area of Science:
- Cardiology
- Inflammation Research
- Biomarker Discovery
Background:
- Acute coronary syndrome (ACS) has high morbidity and mortality rates, with challenges in predicting patient outcomes.
- The inflammatory process is recognized as a key factor in coronary artery disease progression.
- Current prognostic tools for ACS lack specificity, necessitating the search for better predictors.
Purpose of the Study:
- To review the role of inflammation in ACS.
- To evaluate the diagnostic utility of endothelial inflammatory markers (EIMs) as prognostic tools in heart disease.
- To assess if EIMs can predict patient outcomes in ACS more effectively than generalized inflammatory markers.
Main Methods:
- Review of current diagnostic studies on endothelial inflammatory markers (EIMs) in heart disease.
- Analysis of research investigating the link between inflammation and ACS outcomes.
- Comparison of EIMs with generalized inflammatory markers like C-reactive protein for prognostic value.
Main Results:
- Evidence suggests that EIMs may offer greater specificity in predicting outcomes compared to generalized inflammatory markers.
- Not all studies on EIMs have yielded significant results, indicating a need for further research.
- Some EIMs show promise as potential prognosticators in ACS patients.
Conclusions:
- EIMs represent a promising area for developing specific prognostic tools for ACS.
- Further research into EIMs could lead to the identification of easily measurable and cost-effective prognostic markers.
- Improved prognostic capabilities for ACS patients could enhance clinical decision-making and patient management.
Abstract:
Morbidity and mortality rates among patients with acute coronary syndrome (ACS) remain high, and it is difficult to determine which patients will progress satisfactorily and which patients will have poor outcomes. Research has indicated that the inflammatory process is involved in coronary disease. There is great interest within the research community in determining if inflammatory markers could be used to determine the severity of the disease process and therefore serve as a prognostic tool for clinicians. This article describes the inflammatory process in ACS and provides a review of the current diagnostic studies of endothelial inflammatory markers (EIMs) in heart disease. Although research results of EIMs have not all been significant in determining outcomes, there is some evidence that they may be more specific than other generalized inflammatory markers, such as C-reactive protein. Future research of EIMs in patients with ACS might provide evidence of easy-to-measure and economically feasible markers that are sound prognosticators.